| 000 | 01302 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512195648.0 | ||
| 264 | 0 | _c19820917 | |
| 008 | 198209s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1982.tb01888.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrichard, B N | |
| 245 | 0 | 0 |
_aComparison of labetalol with other anti-hypertensive drugs. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cJun 1982 |
||
| 300 |
_a41S-47S p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEthanolamines _xtherapeutic use |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydralazine _xtherapeutic use |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aLabetalol _xadverse effects |
| 650 | 0 | 4 |
_aMethyldopa _xtherapeutic use |
| 700 | 1 | _aRichards, D A | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 13 _gno. 1 Suppl _gp. 41S-47S |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1982.tb01888.x _zAvailable from publisher's website |
| 999 |
_c6124352 _d6124352 |
||